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Abstract
The homing endonuclease gene (HEG) drive system, a promising genetic approach for controlling arthropod populations,
utilises engineered nucleases to spread deleterious mutations that inactivate individual genes throughout a target
population. Previous work with a naturally occurring LAGLIDADG homing endonuclease (I-SceI) demonstrated its feasibility
in both Drosophila and Anopheles. Here we report on the next stage of this strategy: the redesign of HEGs with customized
specificity in order to drive HEG-induced ‘homing’ in vivo via break-induced homologous recombination. Variants targeting
a sequence within the Anopheles AGAP004734 gene were created from the recently characterized I-OnuI endonuclease, and
tested for cleavage activity and frequency of homing using a model Drosophila HEG drive system. We observed cleavage
and homing at an integrated reporter for all endonuclease variants tested, demonstrating for the first time that engineered
HEGs can cleave their target site in insect germline cells, promoting targeted mutagenesis and homing. However, in
comparison to our previously reported work with I-SceI, the engineered I-OnuI variants mediated homing with a reduced
frequency, suggesting that site-specific cleavage activity is insufficient by itself to ensure efficient homing. Taken together,
our experiments take a further step towards the development of a viable HEG-based population control strategy for insects.
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Introduction
The ability to design gene-specific endonucleases against custom
DNA sequences (recently reviewed in [1]) is an essential
component for the targeted gene modification underpinning some
proposed insect eradication strategies. While a number of such
gene targeting nuclease scaffolds exist, including zinc-fingers
(ZFNs) [2], TALENs [3], and the CRISPR/Cas9 system [4,5],
LAGLIDADG homing endonuclease genes (‘HEGs’) encode gene
targeting proteins that offer the advantage of a naturally occurring,
compact monomeric architecture [6]. Directed searches of
microbial genomes have uncovered large families of putative
homing endonuclease genes, a subset of whose recognition sites
can be predicted and validated based on the sequence surrounding
a homing site [7,8]. We have successfully demonstrated that an
endonuclease variant redesigned from a representative of the novel
monomeric LAGLIDADG HEGs, I-OnuI, induced targeted
mutagenesis at the human endogenous gene locus [7].
The HEG drive strategy proposes exploiting the biochemical
activity and homing behaviour of HEGs to drive targeted gene
disruption through an arthropod pest population [9]. This
approach has shown promise in initial evaluations with both
Drosophila melanogaster and the malaria vector, Anopheles gambiae [10–
12]. Considerable development is currently directed towards
deploying the strategy for the control of the latter species. In
models of HEG drive systems, it is strategically advantageous to
target female-specific genes required for fertility [13,14] and a
panel of putative Anopheles gambiae female germline-specific genes
was identified using bioinformatics approaches [15]. Screening this
panel against a library of known target sites for naturally-occurring
LAGLIDADG homing endonucleases yielded a number of hits
that were subsequently ranked by predicted ease of creating
redesigned HEGs [16]. A DNA sequence in AGAP004734, which
only differs from the canonical I-OnuI target site at seven
positions, was chosen for priority development because of the
extensive experience we have accumulated in engineering the I-
OnuI scaffold. Here we report the characterisation of four I-OnuI-
derived endonuclease variants that specifically target a sequence in
the AGAP004734 gene using our previously described Drosophila
in vivo model system [10,12].
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Materials and Methods
Assembly of Active I-OnuI Variants using Yeast Surface
Display
I-OnuI variants cleaving the Anopheles AGAP004734 target were
isolated using multiple rounds of site-directed saturation muta-
genesis (to alter specificity of the wild type I-OnuI) and selection of
active endonuclease variants displayed on the surface of yeast by
fluorescence-activated cell sorting (FACS) [17]. Briefly, Saccharo-
myces cerevisiae (EBY100 strain) were transformed using the lithium
acetate method with a linearized, I-OnuI encoding plasmid and
short DNA fragments containing partial I-OnuI gene sequences
with NNS codons at positions to be randomized. These wobble
bases were introduced by PCR from synthesized oligonucleotide
templates. Residues on the protein-DNA interface that were likely
to participate in recognition of the wild type I-OnuI target site
DNA sequence (by making contacts with DNA bases or backbones
or by interacting with other side chains) were mutated. Cleavage
activity of variant endonucleases was detected by reduced
fluorescence (Alexa-647) signal due to release of cleaved products,
as described previously [17]. In the first round of screening, yeast
cells expressing variant endonucleases that cleaved a DNA
substrate containing a local stretch of sequence from the
AGAP004734 target integrated into the wild type I-OnuI site (see
Figure S1 in File S1 for details) were collected by FACS after an
in vitro cleavage reaction that ran for 20 minutes in 150 mM KCl,
10 mM NaCl, 10 mM HEPES, 5 mM potassium glutamate, 0.5%
BSA, 5 mM MgCl2. Plasmids were recovered from the active
populations (Zymoprep II, ZymoResearch) and subjected to
sequencing. Secondary libraries were designed based on sequence
information from clones selected through the first round of
screening and used to identify active variant genes against each
half of the AGAP004734 target linked to the other half of the wild
type I-OnuI target. Yeast cells displaying active variants were
sorted again as described above and each half domain containing
amino-acid substitutions resulting from site-directed saturation
mutagenesis were assembled to construct a library for selection of
variants that cleaved the full AGAP004734 target site. The I-OnuI
variants cleaving the AGAP004734 target were sorted and
sequenced.
Optimization of I-OnuI Variant Activities using a Bacterial
Two-plasmid Cleavage Assay
The activity of I-OnuI variants generated using the yeast surface
display selections was further optimized using a two-plasmid
selection system in bacterial cells [18]. To obtain variants of I-
OnuI that efficiently cleave the AGAP004734 gene target, the N-
terminal and C-terminal half protein domains of eight unique
clones from the final yeast sort were shuffled by overlapping PCR
and inserted between NcoI and NotI sites of the pEndo expression
plasmid. NovaXGF (Novagen) competent cells harbouring the
pCcdB reporter plasmid (containing 4 copies of the AGAP004734
gene target) were transformed with the pEndo plasmid encoding I-
OnuI variants. The transformants were grown in 26YT medium
(16 g/L tryptone, 10 g/L yeast extract, and 5 g/L NaCl) at 37uC
for 30 min and then diluted 10-fold with 26YT medium
supplemented with 100 mg/mL carbenicillin and 0.02% L-
arabinose (in order to preinduce expression of I-OnuI variants).
After the culture was grown at 30uC for 15 hours, the cells were
harvested, resuspended in sterile water and spread on both
nonselective (16M9 salt, 1% glycerol, 0.8% tryptone, 1 mM
MgSO4, 1 mM CaCl2, 2 mg/mL thiamine, and 100 mg/mL
carbenicillin) and selective plates (the nonselective plates
supplemented with 0.02% L-arabinose and 0.4 mM IPTG to
induces expression of the toxic CcdB protein). After incubation at
30uC for 30–40 hours, the pEndo plasmid was recovered from the
surviving colonies on the selective plates.
The ORFs encoding active I-OnuI variants were amplified via
error-prone PCR using the Gene Morph II Random Mutagenesis
Kit (Agilent Technologies). After digestion with NcoI, NotI and
DpnI, the resulting fragments were recloned into the pEndo vector.
The plasmid was subjected to 2 rounds of selection under
conditions where variant endonucleases were expressed at 30uC
for 4 hours before plating. The selected ORFs were again cloned
into the pEndo vector and used for selection at higher stringency.
Transformed cells carrying both the pEndo plasmid and the
pCcdB reporter were grown in 26YT medium containing 0.02%
L-arabinose at 37uC for an hour and then screened on selective
plates at 37uC for 16–20 hours. The pEndo plasmid was extracted
from colonies on the selective plates and ORFs of the variant genes
carried on the plasmid were sequenced.
in vivo Homing Assay
The Drosophila in vivo homing assay has been previously
described in detail [10]. The assay uses the PC31 integrase
system to place donor constructs expressing a HEG and target
constructs containing the HEG recognition site at homologous
locations in the Drosophila genome [19]. A graphical representation
of the assay is reproduced in Figure S2 in File S1 (originally
published in [12]). As the HEG transcription unit is marked by
mRFP1 and the target site is within an eGFP ORF that is
expressed in the eye, homing of the HEG to the target site can be
readily followed by RFP fluorescence. Disruption of the target site
by NHEJ is also detectable by loss of the GFP fluorescence in
approximately two-thirds of the cases. We previously showed that
a design based on the Rcd-1r promoter and the b-Tub56D 39-UTR
had the best homing performance when comparing a panel of
different construct designs [12]. The constructs used in this study
are modifications of the HEG-2 constructs we previously
described, replacing the I-SceI recognition site with the
AGAP004734 target site. For reasons previously described, we
elected to use the directly-measurable GFP loss (the ratio of GFP-
negative target-bearing progeny count to the total target-bearing
progeny count) and homed fraction (the fraction of GFP-negative
targets derived from homing events) as proxies for HEG activity
and homing efficiency respectively [12].
Bulk crosses were performed in bottles with 5–15 transheter-
ozygote males and ,20 females. Each experiment usually
consisted of three bulk crosses with experiments performed on
two separate occasions and all data from the 5–6 bottles for each
HEG was combined.
As the Rcd-1r promoter drives specific expression in spermato-
gonia, all repair events can be expected to be pre-meiotic resulting
in clusters of 2–16 spermatids that inherit the same lesion. Progeny
genotypes are therefore not independently drawn events with
consequent loss of statistical power. We are not aware of any
treatment that specifically handles this case and have therefore
adopted the expedient of deflating all counts by an effective cluster
size and rounding down the resultant values before they were used
for statistical purposes. This approach provides an approximate
estimate of the actual event counts and since the actual cluster size
is not known, a conservative cluster size of 16 was selected (i.e. the
event is assumed to have occurred in the spermatogonium
immediately after asymmetric division of the germline stem cell,
resulting to the largest cluster size) and it should lead to a
conservative estimate of the statistical significance of comparisons
performed in this study.
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Given that HR occurs only in the spermatogonia in Drosophila
melanogaster, this issue may extend to any experiment investigating
HR using progeny counts in this species.
Characterisation of Repair Products
GFP2 RFP2 progeny were analysed as previously described [6].
The replacement of the I-SceI target site with one derived from
AGAP004734 did not materially affect the assay: PCR amplifica-
tion with the eGFP-L2/eGFP-R2 primer pair resulted in a
fragment of 613 bp. The assay was extended with two further
primers, mRFP-2 (CTC GAA CTC GTG GCC GTT CA) and
Rcd-1r-2 (CCG GTG GGT CAT GTT ATG GT), to permit
identification of incomplete homologous recombination products.
The eGFP-L2/mRFP-2 and Rcd-1r-2/eGFP-R2 primer pairs
amplify the left and right junctions of the homing unit respectively
(Figure S3 in File S1). Sequence alignments were performed with
Clustal-Omega and manually refined [20]. Where the sequence
could be aligned in multiple ways, alignments that preserved the
ATTC overhang at the cleavage site were chosen.
Results and Discussion
Design of I-OnuI to Target the Anopheles Gene Sequence
The candidate AGAP004734 target site differs from the 22 bp I-
OnuI recognition site at 7 positions (Table 1). Using yeast surface
display technology, we isolated nine initial I-OnuI variants that
were capable of cleaving the AGAP004734 target. These genes
were then subjected to random mutagenesis followed by selection
in bacteria to increase cleavage activity (see methods for details). In
bacterial cells, two distinct endonuclease genes, termed ‘H4734A’
and ‘H4734B’, displayed activity similar to the previously
engineered I-OnuI variant that cleaved the endogenous human
monoamine oxidase B gene (1). The new variants contain 17 and 15
amino-acid substitutions, respectively, relative to their parental
enzyme, most of which were located within peptide loops
connecting two b-sheets in the vicinity of each end of the DNA
target site (Figures S4 and S5 in File S1). Of the residues that were
altered in each of the two enzyme constructs, seven positions
harboured the same mutation in both engineered HEGs. Two of
the shared substitutions were introduced on the protein-DNA
interface; two others on a loop of the C-terminal half domain; the
rest relatively distant from the DNA binding surface, but proximal
to one another. Note that the parental endonuclease used to
generate the two AGAP004734 gene targeting nucleases already
possessed four individual amino-acid substitutions (relative to the
true wild type I-OnuI) that were incorporated to improve
expression levels prior to the protein engineering process (Figure
S4 in File S1).
In the two-plasmid cleavage assay employed in the present
study, transformation with an expression plasmid for I-OnuI
rescued bacterial cells that harbour the pCcdB reporter containing
the I-OnuI target sites on the selective medium plates where
expression of the toxic DNA gyrase inhibitor gene was induced
(Table 1). In contrast, the catalytically inactive I-OnuI variant with
a single amino acid substitution in its active site (E22Q) failed to
support cell growth under the same conditions, indicating that
hydrolysis of a target site on the pCcdB reporter plasmid was
essential for cell survival on the selective plates. In this assay,
H4734B displayed slightly higher activity against the AGAP004734
target than H4734A, but cleaved the original wild-type I-OnuI
target with similar efficiency (Table 1). In contrast, H4734A
preferentially cleaved the AGAP004734 target relative to the I-
OnuI target, while retaining levels of activity comparable to
H4734B, thus appearing to retain greater site discrimination
ability than H4734B. The H4734A and H4734B I-OnuI variants
were both further engineered by introducing a previously
identified active site mutation (E178D) that was likely to increase
overall catalytic efficiency, generating enzymes designated as
H4734A* and H4734B* [7].
To evaluate the efficacy of the engineered HEGs in an insect
in vivo gene drive context, H4734A and H4734B and their
derivatives with the E178D substitution were assayed using our
previously described Drosophila model [10]. Transgenic donor lines
containing each of the four HEGs and a recipient line containing
the AGAP004734 target within the GFP ORF were derived by
QC31 integration at the attP2 site on Chromosome 3L. While the
H4734A and H4734B lines were derived without difficulty, the
first generation male founders derived from both E178D variants
were observed to be sterile for several days after eclosion but
eventually became fertile and stocks derived from them could be
maintained under laboratory conditions, albeit requiring greater
care. Reduced fertility was also occasionally observed in subse-
quent crosses where E178D variant lines were used to set up trans-
heterozygotes with the target sequence lines. We speculate that the
initial sterility arose as a result of more promiscuous activity by
E178D variants, creating double-strand breaks at genomic loci
other than the recipient target. Since these break sites can be
repaired by nonhomologous end joining (NHEJ) that frequently
induces short sequence deletions and insertions, leading to
disruption of sites cleavable by engineered HEGs, we suspect that
only such clones eventually dominated the male germline. The
transmission of these non-cleavable sites to progeny eventually
result in more fertile transgenic E178D lines.
HEG Activity and Homing Performance in vivo
A brief description of the in vivo assay is available in Figure S2 in
File S1. We observed that all HEGs showed cleavage activity
against the AGAP004734 target in the in vivo Drosophila assay, but,
in contrast to the in vitro assay where the H4734A variant was less
active than H4734B, both variants showed similar activity in vivo.
However, both H4734A and H4734B were considerably less
active than I-SceI in our Drosophila assay, yielding less than half the
GFP loss induced by the latter when driven by the same regulatory
elements at the same chromosomal location. In line with
expectations, the inclusion of the E178D substitution increased
activity to a level corresponding to near-complete loss of GFP
expression, presumably through increased enzymatic activity,
Table 1. Activity of parental and variant endonucleases in
bacteria.
Target sites1,2
Endonuclease I-OnuI AGAP004734 gene
I-OnuI 98% ,0.010%
Inactive I-OnuI (E22Q) ,0.010% n.d.*
H4734A 0.049% 40%
H4734B 55% 56%
1Values indicate the percentage of survival rate, which is calculated by dividing
the number of colonies on the selective plates by that on the nonselective
plates.
*not determined.
2The recognition sites of I-OnuI and the AGAP004734 target site are:
AGAP004734 TgTCCACac ATTC AAaCTTaac.
I-OnuI T TT C TTA.
doi:10.1371/journal.pone.0074254.t001
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although other mechanisms are formally possible, e,g, a shift from
religation to HR/NHEJ-mediated repair.
Using fluorescent markers as a readout, all four of the
engineered HEGs showed a lower homed fraction than I-SceI
when assayed under the same conditions, having half the homing
fraction of I-SceI (Table 2, row 2). The homing fraction was not
significantly different among I-OnuI transgenic lines (Fisher’s p-
value = 0.48). However, the fraction of RFP+ (as a marker of
homing) progeny from the H4734A*2 or H4734B*2 expressing
parents was comparable to that from the I-SceI-expressing line
(Table 2, row 3), because these two engineered I-OnuI variants
appeared to cleave their target site more effectively than I-SceI.
The lesions at the cleavage site of GFP2, RFP2 progeny (i.e.
cases of presumptive NHEJ repair) were characterised by PCR
amplification and sequencing. The majority of lesions were typical
of HNEJ repair, with micro-deletions at the cleavage site (Figure
S6 and Table S1 in File S1). Most micro-deletions appeared to
occur on either side of the ATTC overhang sequence with that
sequence preserved intact, although this interpretation could be an
artefact of the alignment procedure in some cases. In the few cases
where micro-deletions were absent, the region around the cleavage
site was either duplicated or a few bases were inserted from an
unknown template. Oversized PCR fragments were very occa-
sionally obtained (Table S1 in File S1) and two of these were
sequenced and found to have incorporated the sequences at the
junctions of the homing unit and the target site (Figure S3 in File
S1). The occurrence of partial HR raised concerns that we may
have previously incorrectly interpreted cases where no PCR
product was obtained with the eGFP-L2/eGFP-R2 primer pair as
large deletions arising from NHEJ instead of being the result of
extensive but incomplete HR. A further 28 samples that did not
yield PCR products were analysed by amplifying across the
junctions of the integrated homing unit (Figure S2 and Table S1 in
File S1). In one sample, sequences from both junctions were
detected while sequences from the right junction only were
detected in a further two samples. This indicated that while
incomplete HR occurs more frequently that we had considered
hitherto, the majority of cases (,90%) where a PCR product is not
obtained by PCR across the cleavage site are appropriately
attributed to larger deletions. The incomplete HR products are
consistent with a previously-proposed model that HR in Drosophila
progresses by multiple cycles of strand invasion, synthesis and
dissociation of the nascent strand [21].
Unexpectedly, our results show that the propensity for HR
repair of double-strand breaks (DSBs) varies depending on the
target/nuclease combination. Both the I-SceI and engineered I-
OnuI variant nucleases generate DSBs with four-base 39-
overhangs, yet the former is more readily resolved by HR than
the latter. The difference could either be a consequence of the
immediate sequence context of the DSB or by differences in the
rate of nuclease dissociation from the cleaved DNA sequence,
thereby delaying access by the repair machinery to the lesion.
Studies focused on the factors that control the outcome of targeted
DSBs (both repair and homing) are a clear area for future
investigation.
Perspectives into Deploying a HEG Drive System
The results from this first detailed investigation of custom HEGs
designs for use in insect HEG gene drive have yielded some
insights. On a positive note, they indicate that HEGs designs are
active for cleavage and homing in an in vivo HEG drive system.
The AGAP004734-targeted HEGs cleave their intended targets
and mediate homing. In addition, these variant endonucleases are
sufficiently target-specific such that expression can be tolerated in
the male germline without permanent sterility, even when
combined with the activity-enhancing, specificity-compromising
E178D substitution. However, while stocks bearing the latter can
be maintained in laboratory conditions, their fitness may be too
impaired to be maintained in a wild population after release.
Our results also identify hitherto unexpected challenges to be
addressed, and show that DNA strand hydrolysis catalysed by
HEGs is not the sole factor that determines efficient homing.
Approaches to HEG redesign currently focus exclusively on
optimising cleavage activity and specificity, with the assumption
that robust site-specific cleavage should lead to homing at a high
frequency. However, very little is known about what selects a DSB
repair pathway to fix a break site and it is therefore essential to
identify these determinants if we wish to effectively exploit HEGs
for control of insect-borne diseases. Our Drosophila model provides
a uniform, straightforward platform to assess the efficiency of
HEG-mediated homing event in vivo. Since transgenesis is
considerably more difficult in Anopheles than Drosophila, the model
system used here will help to screen for HEG designs with
characteristics appropriate to be tested in Anopheles.
Supporting Information
File S1 Combined supplementary information file containing
Figures S1–S6 and Table S1. Figure S1, Schematic of an approach
to isolating the AGAP004734 gene targeting nucleases using yeast
surface display technology. Figure S2, Homing assay. Figure S3,
Schematic of PCR primer locations. Figure S4, Sequence
alignment of the wild type I-OnuI, two engineered I-OnuI
variants cleaving the AGAP004734 gene target (H4734A and
H4734B), and their parental enzyme (parental I-OnuI). Figure S5,
Positions of substituted residues in the H4734A (a) and H4734B (b)
Table 2. Results for AGAP004734-target HEGs.
I-SceI1 H4734A H4734A* H4734B H4734B*
Percentage[CI](Counts) Percentage[CI](Counts) Percentage[CI](Counts) Percentage[CI](Counts) Percentage[CI](Counts)
GFP2/total 37 [31–44](1273/3422) 162 [11–21](509/3251) 872,3 [83–91](3682/4218) 132 [9–19](362/2860) 862,3 [79–90](2007/2347)
Homed/GFP- 61 [50–71](782/1273) 332 [19–50](168/509) 292 [24–35](1077/3682) 302 [13–48](107/362) 222 [16–30](451/2007)
Homed/total 23 [17–29](782/3422) 52 [3–8](168/3251) 26 [21–31](1077/4218) 42 [2–7](107/2860) 19 [14–26](451/2347)
1Previously reported in [10].
2Different from equivalent I-SceI value (Fisher’s exact test p-value,0.02).
3Different from equivalent non-E178D value (Fisher’s exact test p-value,0.02).
95% confidence intervals are listed above.
All calculations were based on the conservative assumption described in methods.
doi:10.1371/journal.pone.0074254.t002
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endonucleases. Figure S6, Repair Lesions. Table S1, PCR analysis
of repair products of I-OnuI derivatives.
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